tiprankstipranks

Thomas Gad Insider Profile

4 Followers
Thomas Gad, CBO, Director at Y-Mabs Therapeutics, holds 309.21K shares in Y-Mabs Therapeutics (Ticker: YMAB).
tipranks
Thomas Gad

Thomas Gad
Y-Mabs Therapeutics (YMAB)
CBO, Director

Ranked #8,027 out of 99,335 Corporate Insiders

Profitable Transactions

71%
15 out of 21 Profitable Transactions

Average Return

+11.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Thomas Gad's holdings

Insider Roles

Y-Mabs Therapeutics
(YMAB)
CBO, Director
Roles that Thomas Gad holds in companies

Most Profitable Insider Trade

Stock:
Y-Mabs Therapeutics
(YMAB)
Rating:Informative Sell
Date:Nov 26, 2021 - Nov 26, 2022
Return:+75.50%
The most profitable trade made by Thomas Gad

Thomas Gad's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Y-Mabs Therapeutics
Sep 20, 2024
CBO, Director
Uninformative Buy
100.00K
$3.22M
Success Rate for
YMAB
15 out of 21 profitable transactions on
YMAB
71%
Average Return for
YMAB
Average return per transaction on
YMAB
+11.44%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 12, 2021
Uninformative Buy
$0.00
-
$0.00
Dec 16, 2021
Uninformative Buy
$0.00
-
$0.00
Jan 19, 2023
Uninformative Buy
$0.00
-
$0.00
Jan 22, 2024
Uninformative Buy
$0.00
-
$0.00
Sep 15, 2020
Uninformative Buy
$100.00K
-
$2.00
List of latest transactions for each holding click on a transaction to see Thomas Gad's performance on stock

Thomas Gad insider profile FAQ

What is the percentage of profitable transactions made by Thomas Gad?
The percentage of profitable transactions made by Thomas Gad is 71%.
    What is the average return per transaction made by Thomas Gad?
    The average return per transaction made by Thomas Gad is 11.40%.
      What stocks does Thomas Gad hold?
      Thomas Gad holds: YMAB stocks.
        What was Thomas Gad’s latest transaction?
        Thomas Gad latest transaction was an Uninformative Buy of $100.00K.
          What was Thomas Gad's most profitable transaction?
          Thomas Gad’s most profitable transaction was an Informative Sell of YMAB stock on November 26, 2021. The return on the trade was 75.50%.
            What is Thomas Gad's role in Y-Mabs Therapeutics?
            Thomas Gad's role in Y-Mabs Therapeutics is CBO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.